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AbstrAct
Objectives To determine communication strategies 
associated with smoking cessation in the National Health 
Service community pharmacy Stop Smoking programme.
setting 11 community pharmacies in three inner east 
London boroughs.
Participants 9 stop smoking advisers and 16 pairs 
of smokers who either quit or did not quit at 4 weeks, 
matched on gender, ethnicity, age and smoking intensity.
Method 1–3 audio-recorded consultations between an 
adviser and each pair member over 5–6 weeks were 
analysed using a mixed-method approach. First a content 
analysis was based on deductive coding drawn from a 
theme-oriented discourse analysis approach and the 
Roter Interaction Analysis System. Core themes were 
identified through this quantification to explore in detail the 
qualitative differences and similarities between quitters 
and non-quitters.
results Quantitative analysis revealed advisers used 
a core set of counselling strategies that privileged 
the ‘voice of medicine’ and often omitted explicit 
motivational interviewing. Smokers tended to quit when 
these core strategies were augmented by supportive 
talk, clear permission for smokers to seek additional 
support from the adviser between consultations, 
encouragement for smokers to use willpower. The 
thematic analysis highlighted the choices made by 
advisers as to which strategies to adopt and the 
impacts on smokers. The first theme ‘Negotiating 
the smoker–adviser relationship’ referred to adviser 
judgements about the likelihood the smoker would 
quit. The second theme, ‘Roles of the adviser and 
smoker in the quit attempt’, focused on advisers’ 
counselling strategies, while the third theme, ‘Smoker 
and adviser misalignment on reasons for smoking, 
relapsing and quitting’, concerned inconsistencies in 
the implementation of National Centre for Smoking 
Cessation and Training recommendations.
Discussion Advisers in community pharmacies should 
use the advantages of their familiarity with smokers to 
ensure appropriate delivery of patient-centred counselling 
strategies and reflect on the impact on their counselling of 
early judgements of smoker success.
IntrODuctIOn
UK community pharmacies have adopted 
public health and healthy living tasks that 
were previously the domain of the general 
practitioner.1 These ‘enhanced services’ 
are embedded in UK health service policy 
and embraced by pharmaceutical profes-
sional bodies.2–9 Community pharmacies 
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Research
strengths and limitations of this study
 ► To our knowledge, this is the first study to consider 
verbal interactions in real-world consultations 
between community pharmacy advisers and 
smokers in the National Health Service community 
pharmacy Stop Smoking programme.
 ► Thirty-two smokers from a larger sample were 
matched on demographic variables to provide 16 
matched pairs of 4-week quitters and non-quitters, 
enhancing confidence in findings.
 ► The findings may not be transferable to other 
pharmacies, particularly in less disadvantaged 
areas or to over-the-counter community pharmacy 
interactions since the consultations took place in 
dedicated consultation rooms.
 ► Our study findings are limited to interactions during 
the consultation, as appropriate to the methods 
chosen, and we did not systematically explore 
previous quit attempts and their influence on results.
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have great potential to provide such healthcare, partic-
ularly for people from disadvantaged groups,10 given 
their community setting, long opening hours, acces-
sibility, familiarity and informality.11–13 Pharmacy-en-
hanced services therefore provide an opportunity to 
address health inequalities and may free general prac-
tice time for patients with more complex problems.14
The National Health Service (NHS) Stop Smoking 
programme is one of the most frequently delivered 
enhanced community pharmacy services in England15 16 
and its effectiveness in 2015/2016 measured by smoker 
self-reported 4-week quit rates was only slightly lower 
than for general practice (44% vs 49%).17 But neither 
general practice nor community pharmacies achieve 
the suggested optimal quit rate of 70%,7 and there is 
considerable variation in rates within the same setting.17 
Moreover, the proportion of smokers enrolling on the 
Stop Smoking programme in community pharma-
cies rather than general practitioner (GP) surgeries 
and other settings has remained stable since the 
programme began in 2006, falling between 18% and 
21%, for example 20% in 2015/2016.7 17 This is despite 
government efforts to shift some of the GP workload to 
them.7 15
Enhanced services have necessitated a change in 
mind set for pharmacy staff with a move towards the 
person-centred care model currently advocated within 
health services.17–26 Pharmacy staff tend to be inade-
quately trained in this model24 and may lack necessary 
consultation skills,24 26 which may affect the growth of 
the Stop Smoking service in pharmacies. We therefore 
used a ‘focused ethnography’ approach27 28 to explore 
counselling strategies used in consultations between 
pharmacy Stop Smoking advisers and smokers. Our 
primary aim was to use the findings to develop an 
intervention intended to improve both service uptake 
and quit rates in the community pharmacy Stop 
Smoking programme, as reported elsewhere.29
MethODs
Focused ethnography
Using focused ethnography27 28 we collected and anal-
ysed recordings of naturalistic (real world) consultations 
between pharmacy Stop Smoking advisers and smokers; 
recordings were made by the advisers themselves for 
the study. We considered verbal interactions that might 
affect smoker engagement, maintenance within the 
pharmacy programme and success in quitting.
In traditional ethnographic work, researchers immerse 
themselves in the social worlds of their participants 
to better understand the ways they interact with these 
worlds. They then generate textual or visual accounts of 
this for dissemination.30 In focused ethnography, field 
visits are either much shorter and selectively focused or 
replaced by audio, video or photo recordings which may 
be undertaken with the researcher absent from the scene, 
as in our study. This approach is useful for answering a 
specific research question when traditional ethnography 
is impractical.28
Pharmacies and advisers
Consultations were recorded between November 2013 and 
May 2014 at community pharmacies contracted by Public 
Health England to provide the Stop Smoking programme 
in three inner East London boroughs (Newham, Tower 
Hamlets, City and Hackney). These areas are economi-
cally disadvantaged compared with other areas of London 
and with England as a whole31 and have relatively poor 
NHS Stop Smoking programme attendance.13 15 16 We 
only included community pharmacy chains or indepen-
dent single pharmacies, which are distinct from those in 
institutional settings such as NHS hospitals. Consultations 
had to take place in a private room. Only the adviser and 
smoker were present though sometimes the consulta-
tions were interrupted as they often took place in rooms 
that doubled as store rooms, which other staff needed to 
access.
To select pharmacies, we used maximum variation 
sampling by borough, pharmacy size and length of time 
on the Stop Smoking programme. Within pharmacies, 
we invited any staff members certificated through the 
National Centre for Smoking Cessation and Training 
(NCSCT) programme, with a mixture of pharmacists 
and counter assistants therefore included in the study. 
We considered sampling for variation in years spent 
counselling for smoking cessation and in certification 
level in the NCSCT, but there was too much missing 
data for this to be useful. In any case, our focus was 
on the interaction between smoker and adviser per 
se. We visited pharmacies on spec or by appointment, 
explained the study and if relevant took consent and 
trained them in research methods and governance, so 
that they could take smoker service user consent and 
record, securely store and transfer their own consul-
tations to the research team. This meant the natural 
rhythm of the service was not disrupted. Ethical approval 
for the study was obtained from the National Research 
Ethics Service Committee South Central, Berkshire B 
(reference number 13/SC/0189).
smokers
All adult smokers recruited onto the NHS Stop Smoking 
programme during the course of the study were eligible 
and invited to join the study by the pharmacy adviser. 
Smokers were designated as having quit if they self-re-
ported a smoke-free status at 4 weeks after their set quit 
date and provided an adviser with an expired carbon 
monoxide (CO) reading of less than seven parts per 
million using a CO monitor. Smokers lost to follow-up 
at 4 weeks were considered still smoking following the 
Russell criteria.32
Data collection
Community pharmacy NHS Stop Smoking programme 
consultations and prescriptions for medication may 
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Figure 1 Analysis process. RIAS, Roter Interaction Analysis System.
continue for up to 12 weeks with formal consultations 
weekly or 2 weekly and informal drop-ins between these 
times as needed.7 33 The core period for the programme 
ends at 5 to 6 weeks which tends to equate with the 
fourth week after the quit date, usually set at the first 
consultation.7 33
In line with our focused ethnography approach, Stop 
Smoking advisers consented eligible smokers and selec-
tively audiorecorded:
 ► Their first consultation, which tends to set the param-
eters for the remaining sessions, includes the smoker 
setting a proximal quit date and is usually up to three 
times as long as subsequent sessions (averaging 15 min 
vs 5 min)34;
 ► The consultation at 2 weeks post proposed quit date 
where the adviser explores and attempts to solve any 
issues in the quit attempt;
 ► The consultation at 4 weeks post proposed quit date at 
which the smoker’s quit status is formally designated 
(as the 4-week quit status) for Public Health England 
audit statistics and pharmacy remuneration35 (see 
Sohanpal et al36 for a discussion of remuneration in 
relation to our larger study).
We call these weeks 1, 2 and 4 for simplicity. Recordings 
were anonymised and transcribed as they were received. 
Pseudoanonymised metadata (such as demographic data 
and smoking intensity for the smokers and training and 
demographic data for the advisers) were entered with 
anonymised recordings and transcripts onto a secure clin-
ical trials database.
Matched pairs
We refer to quitters and non-quitters throughout this 
paper, but in consultations 1 and 2 this is a retrospec-
tive designation for eventual quitters and non-quitters. 
We matched 16 pairs of 4-week quitters and non-quitters 
(ie, 32 smokers) on gender, ethnicity, age (according to 
UK Office for National Statistics [ONS] age bands) and 
smoking intensity (fewer than 10 cigarettes a day, 10–20 
a day, more than 20 a day). We had initially aimed for 
20 matched pairs but obtained saturation at this lower 
number and so stopped data collection at this point.
consultations analysis
We used a mixed-methods analysis approach, in which 
themes were identified deductively and inductively and 
then quantified (figure 1). First, we developed deduc-
tive themes from a list of: the key linguistic devices used 
in theme-oriented discourse analysis,37 which considers 
how language use constructs professional practice; 
and the structuring of the medical consultation in 
the Roter Interaction Analysis System (RIAS),38 which 
is a widely used method for coding and quantitatively 
analysing the conversational strategies used structur-
ally in medical consultations. Our approach thus has its 
origins in psycholinguistics and its purpose is to look at 
what talk itself is doing as constitutive of social action 
rather than as representational of inner psychological 
states, behaviours, beliefs or attitudes.37
The core team then applied the deductive themes to 
the consultation transcripts and also looked for emer-
gent (inductive) themes,39 40 immersing themselves in the 
data, reading and rereading each consultation transcript 
and meeting to discuss themes. CR led development of 
themes from the data. The team constantly compared 
deductive and emerging inductive themes with each 
other and also compared data within themes to ensure 
each emergent theme was discrete from all other themes 
and representative of the relevant data.39 40 CR operation-
alised the themes, for a second researcher (RS) to code 
20% of the data independently. Differences were recon-
ciled by discussion, until a Cohen’s kappa statistic of 76% 
was obtained.
Once themes were determined, a quantitative summary 
of these was developed. First, for each theme we quantified 
the number of smokers whose consultations included the 
4 Rivas C, et al. BMJ Open 2017;7:e015664. doi:10.1136/bmjopen-2016-015664
Open Access 
theme (A of table 1). This suggested what strategies were 
typically used in the counselling sessions (thus a core set 
of strategies). We also calculated the average frequency 
of use of a theme within consultations in which it was 
mentioned (D of table 1) by dividing the total number of 
occurrences of a theme across all consultations (column 
C of table 1) by the number of consultations in which it 
occurred (column B of table 1). We only counted one 
occurrence in each ‘turn’ the smoker or adviser took to 
talk (where a conversation is made up of lots of turns at 
talking). This gave us a measure of the relative importance 
of each theme; a theme with an average frequency of 1 
may be considered less important overall than a theme 
with an average frequency of 4, that is, it may be used 
only in very specific circumstances or idiosyncratically. To 
obtain the frequency measure, we divided by the number 
of consultations with a mention of the theme rather than 
all consultations because we wanted a measure that indi-
cated repetitions. We could have provided an alterna-
tive measure of the relative bias towards a theme within 
consultations by dividing the number of mentions of all 
themes in each consultation by the number of mentions 
of each specific theme. However, this measure would be 
sensitive to the absence of other themes because they 
were not relevant (for example because the 3 weeks we 
recorded had different foci) or because they had been 
covered outside of the recording. For similar reasons 
we did not quantify the number of words used for each 
theme.
With all quantitative measures (as with the qualitative 
analysis) we looked for similarities and noted any differ-
ences between eventual quitters and non-quitters. We 
used the quantitative measures to give us a broad picture 
of the consultations and themes so that we could deter-
mine which to explore in more detail qualitatively. We 
focused on themes that were associated with quit success 
or lack of success and that were of high or moderate 
frequency of use across consultations or that appeared to 
be core to the sessions. We also considered strategies that 
were rarely used but that might be important for service 
improvement. This led to a list of key themes, which we 
report on in more detail in the next section. Given the 
small numbers involved, tests of significance are not 
reported here.
FInDIngs
Participants
Thirty-nine per cent (11/28) of recruited advisers 
provided 158 audiorecordings from 53 smokers; two 
further pharmacies dropped out due to lack of time. 
Considering only the 16 matched pairs, these were seen 
by 9 of the 11 advisers, with a median of 3 smokers each 
(range 1–7). Table 2 compares baseline characteristics of 
the matched pairs to the total sample. While women were 
under-represented in the matched pairs, other character-
istics related to cessation outcome were broadly similar. 
This includes medication use; though we did not monitor 
for this systematically, the transcripts indicate that similar 
numbers of quitters and non-quitters were on vareni-
ciline, for example. Most advisers in the total group were 
male (89%) and from pharmacies in City and Hackney 
(89%). Sixty-seven per cent of advisers were Indian, and 
11% were from other black and minority ethnic groups, 
with missing ethnicity data for one. Importantly, find-
ings were similar whether the adviser was a pharmacist 
or trained counter assistant. With one exception, there 
was no indication of a lesser authority in counter assis-
tants since they, like the pharmacists, had received special 
training in smoking cessation counselling. The exception 
had only recently been trained and was being shadowed 
by the pharmacist. The small number of advisers in the 
study precluded analysis of the effect of other variables 
on the consultation. In any case our analysis was focused 
on what talk itself does and was not intended to explore 
these effects.
themes
Thematic analysis reached saturation and revealed three 
overarching themes in the data:
 ► Negotiating the smoker–adviser relationship;
 ► The roles of the adviser and the smoker in the quit 
attempt;
 ► Smoker and adviser misalignment on reasons for 
smoking, relapsing and quitting.
These were made up primarily of the subthemes devel-
oped deductively from psycholinguistics as described in 
the methods. Table 2 provides a quantitative overview of 
the themes and selected subthemes based primarily on 
the RIAS and theme-oriented discourse analysis, which 
we focus on in this paper, and compares quitters and 
non-quitters. We follow this with a narrative description 
of themes; extracts are identified by smoker (P), adviser 
(A) and consultation week (W) while the quantifiers 
most, common or many, occasionally or some and a few 
or rarely refer to a theme occurrence of 75%+, 50%–74%, 
25%–49% and less than 25%. Identification numbers 
used by us to manage the data are also used to attribute 
extracts from the data in the narrative text. The first 
consultation should consider smoker tobacco use and 
motivation to quit (some advisers used a questionnaire 
type script) and subsequent ones build on this. Here, we 
focus on what the talk does within any adviser–smoker 
interaction and the association of interaction strategies 
per se with quitting or not, hence aggregating the data 
across consultations, while mindful of which consulta-
tions they represent. We consider the data by consultation 
sequence in further analyses to be reported elsewhere, 
which support the findings of this paper.
From the quantitative data, we determined that the 
core set of strategies used by advisers (occurring in 50% 
or more of smokers) were praise, biomedical talk and 
advice, mention of the side effects of medication, collabo-
rative talk, the use of props and strategies to cope with the 
urge to smoke and the use of monitoring and surveillance 
talk. Significantly, explicit use of motivational talk is not 
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included in this core set.41 Further strategies were added 
to the core set in eventual quitters: talk on the impor-
tance of support; open door talk and the need for will-
power. Managing expectations formed part of the core 
set for non-quitters only. These themes are discussed in 
more detail below.
Negotiating the smoker–adviser relationship
Lifeworld talk was common across the groups, though 
occurring in slightly more eventual quitters and with 
more occurrences within their consultations. This is talk 
about a person’s experience of life with all its contextual 
and situational nuances.42–45 Through lifeworld talk, the 
advisers gained a shared understanding with the smoker 
of the context of the smoker’s quit attempt and the indi-
vidual difficulties they faced. The adviser could then 
discuss approaches to quitting that took into account 
such things as the stress that the smoker in the following 
extract describes.
A: So while you’re on Champix and you left work and 
you’re a bit stressed did you say?
S: Yeah, because there’s many changes in the work 
you remember when you told me in the beginning, 
like try to, don’t change the work and the things. 
But they change our store manager, my manager is 
leaving. The work we used to do, six persons now 
going to be in two persons, oh my god. It’s just,
A: So you’re a bit more stressed at work.
S: Terrible. It’s terrible.
A: So you came home and you’re a bit stressed still, 
so you felt like you wanted a cigarette? But you didn’t 
have a cigarette? (P807-A81-W4, quit)
The advisers made it clear to around one quarter of 
smokers that they were not going to judge them for any 
lapses and failures, as a way to motivate them to continue 
the programme, illustrated in the following extract. This 
is in line with good practice.
A: Fantastic. So again, my idea is to mentor you and 
support you and that’s what it’s about, yeah? I’m not 
here to tell you off. It’s about where you’re finding 
it hard and what we need to work together to find a 
solution for you. (P107-A1-W1, quit)
Praise was common across groups, but with marked 
qualitative differences. Quitters received limited and 
brief praise. By contrast, eventual non-quitters were given 
extensive (extreme formulation46 47) praise even when 
they had not achieved the NCSCT-recommended ‘not a 
puff’, as below.
S: Well, it’s actually helped a lot, so I’m only smoking 
around ten.
A: Ten plus? Ten to fifteen?
S: Ten plus.
A: That’s fantastic. In the space of six, 7 days you’ve 
cut down by over half. (P4-A1-W2, not quit)
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Table 2 Smoker demographic and smoking data summaries for total number sampled and for the matched pair groups
Variable Quitters (16) Non-quitters (16; 6 LTF) All (53; 9 LTF)
Female 3 (19%) 3 (19%) 18 (34%)
Age (median, range) 47 (26–58) 41 (28–59) 41.13 (18-67)
Occupation
  Managerial and professional 2 (13%) 0 5 (9%)
  Unemployed 10 (63%) 10 (63%) 25 (47%)
  Routine manual 3 (19%) 3 (19%) 8 (15%)
  Student 0 0 1 (2%)
  Intermediate 0 2 (13%) 7 (13%)
  Retired 0 0 1 (2%)
  No answer 1 (6%) 4 (25%) 6 (11%)
Ethnicity
  White British 11 (69%) 9 (56%) 30 (57%)
  South Asian 3 (19%) 3 (19%) 8 (15%)
  Other white 2 (13%) 3 (19%) 10 (19%)
  Black African 0 0 1 (2%)
  Black Caribbean 0 0 1 (2%)
  Missing data 0 1 (6%) 2 (4%)
Cigarettes smoked
  40 1 (6%) 0 1 (2%)
  30 2 (13%) 2 (13%) 5 (9%)
  25 3 (19%) 3 (19%) 8 (15%)
  20 7 (44%) 9 (56%) 25 (47%)
  15 1 (6%) 2 (13%) 5 (9%)
  <15 2 (13%) 1 (6%) 9 (17%)
London Borough
  Tower Hamlets 2 (13%) 5 12 (23%)
  City and Hackney 14 (88%) 10 38 (72%)
  Newham 0 0 3 (6%)
LTF, lost to follow-up.
Roles of the adviser and the smoker in the quit attempt
Biomedical information and advice was imparted across 
the groups but quitter consultations were most heavy 
with it. This may mean they were more open to biomed-
ical talk or that the adviser got an impression that they 
were or it may be an incidental finding. Side effects of 
the medication and withdrawal symptoms from stopping 
smoking, including weight gain, were discussed with 
many smokers. The possibility of relapse was discussed 
with only 25% of quitters and 19% of non-quitters. 
There was some compensation in the degree to which 
the use of strategies to deal with cravings (hence risk of 
relapse) was commonly encouraged (see extract later in 
this section).
Advisers made attempts to manage many of the even-
tual non-quitters’ expectations of the programme as well 
as emphasising their required commitment. Both strat-
egies were undertaken only occasionally with quitters. 
Many quitters but only some non-quitters were told of the 
importance of advisers’ counselling support. Advisers’ 
motivational talk was occasional in both groups and did 
not form part of the core set of strategies and advisers 
only rarely asked for (and therefore got) expressions of 
confidence in being able to quit (three quitters over eight 
consultations vs one non-quitter over two consultations), 
a specific element of motivational interviewing. The need 
for the smoker to draw on their own willpower to quit was 
considered in most quitters but only some non-quitters, 
and the necessary balance between adviser support and 
more personal willpower or motivation was only discussed 
with one non-quitter (in the following extract) and one 
quitter.
S: I’ve got a photograph of me taken when I was in 
intensive care in hospital, I should take a look at that 
every time I want a cigarette.
A: Perfect! You need some motivation.
S: I don’t want to end up like that again.
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A: Exactly, you need that motivation. And if there’s 
anyone else that can help you also…
S: My mum, yeah, she’s very supportive.
A: Sure. You need that support as well. But you’ve got 
us as well because you’ll be coming here every week. 
(P806-A81-W1, not quit)
Collaborative talk (such as the use of the phrase ‘we will 
succeed’), a supportive stratagem, was common in both 
groups. The related topic ‘smoker’s ownership of the 
quit’ was rarely mentioned in non-quitter consultations 
and only slightly more so in quitters’. Some messages 
were implied rather than explicit. The use of props and 
strategies to deal with cravings requires some ownership 
and self-management of the quit and was recommended 
at least once in a majority of smokers and consultations, 
though more frequently discussed within quitter consulta-
tions. Many different props and strategies were suggested, 
with the following only one example.
A: I want you to make sure you start off in the 
morning; you’ve got your bottle of one point five 
litres to two litres. Your aim, you start in the morning, 
you finish at the end of the day. Every time you want 
a cigarette, you’re going to drink the water. You’re 
going to complete it. (P101-A11-W1, not quit).
The advisers invited many smokers to drop into the 
pharmacy for support and advice any time the shop was 
open, a particular advantage that pharmacies have over 
other healthcare settings. Such ‘open door’ talk, offering 
a more informal variant of adviser support, was said to 
fewer eventual non-quitters and was less successful for 
these.
In most smokers, the CO monitor was depicted by 
the adviser as a monitoring or surveillance tool that was 
used to check the smoker’s progress and even catch the 
smoker out:
A: Well, it’s good that you’re here, we will help you in 
any way we can. What I ask you every week is if I can 
take a reading from you. This is called a CO monitor 
and this machine measures the amount of carbon 
monoxide inside of your system. And I call this my lie 
detector. I’m not going to say that you’re going to lie 
to me, but if you do come in and I say have you had 
any cigarettes, and you say no, I haven’t had any, this 
will tell me the truth. (P7-A1-W1, quit)
Smoker and adviser misalignment on reasons for smoking, 
relapsing and quitting
An actual health problem or worry about getting one was 
cited as a reason to quit by more than half the smokers 
and was invoked slightly more commonly by non-quit-
ters. There was an inverse relationship between this and 
adviser use of health scare tactics to motivate the smoker, 
though these tactics were relatively uncommon. Finan-
cial reasons for wanting to quit were cited by just under 
one-third of smokers. However, the advisers tried to 
motivate the smokers with talk of financial savings on 23 
separate occasions. Initial misalignment is demonstrated 
in the following extract for example; though there is 
evidence of subsequent ‘repair’ of this at the end of the 
extract, our focus in the current analysis was on whether 
misalignment arose at all.
S: I mean I don’t want to die. I don’t want to have a 
stroke.
A: So that’s your main impulse now and more likely 
you’ll succeed because of that.
S: I don't want to end up like that…
A: The other reasons why maybe you feel I’ll give up 
now, maybe save a bit of money or whatever before…
S: That’s the backburner, that’s nothing to do…
A: Exactly. Was that the reasons before?
S: No.
A: What were the reasons before that you wanted to 
stop smoking?
S: Smell; I don’t like the smell. I’ve got this thing, 
when I eat, people smoke around me, I don’'t like it, I 
don’t like the smell of it when I’m eating. People light 
one up when you’re having something to eat and oh, 
it’s disgusting, I don’t like the smell. (P806-A81-W1, 
not quit)
Quitters were twice as likely to mention their families 
(including children) as motivation though under a third 
did so. Other reasons for smoking were cited relatively 
infrequently. Notably the misalignment or mismatch 
between smoker declaration of health as motivation to 
quit and adviser comments on health problems caused 
by smoking was more likely in non-quitters, and advisers 
were also less likely to mention motivational factors at 
all to eventual non-quitters. In quitters’ consultations, 
advisers were likely to mention motivators, especially 
financial, even when the smoker did not.
DIscussIOn
We applied rigorous and systematic analytical methods 
to a sample of audiorecordings of real-world community 
pharmacy adviser–smoker NHS Stop Smoking consul-
tations with the premise that the community pharmacy 
Stop Smoking programme should be person-centred. 
Specifically, we explored associations of thematic patterns 
in the verbal interactions with 4-week quit success. 
Although there are a number of ethnographic studies of 
client–pharmacy staff communication processes or inter-
actions,24 38 48–71 there is none on stopping smoking in 
the community. Our overall findings accord with those 
of Pilnick’s study49–51 in a UK hospital paediatric outpa-
tient clinic pharmacy, the most comparable study to ours, 
which focused on advice giving in the counselling role, 
but we provide rich new data.
There were some clinically potentially significant omis-
sions across the data. For example, talk about relapse was 
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rare, though there was some compensation in the degree 
to which the use of strategies to deal with cravings was 
frequently encouraged and the biomedical problems 
of quitting often explored. We found many examples 
of good practice, including significant evidence of life-
world talk,42 43 which was common across the two groups. 
Mishler,43 applying the Habermas theory of Communica-
tive Action72 to medical encounters, itself derived from 
Husserl’s phenomenological concept of consciousness 
and subjectivity,44 showed how this enables person-cen-
tred support. It provides the pharmacy advisers with the 
smokers' own nuanced and contextualised73–81 accounts 
of their personal daily lives, in which they manage their 
quit attempts. When the adviser uses these to shape their 
recommendations, advice and medical support, adviser 
consultations are more likely to be effective.44 82 The 
occurrence of lifeworld talk in our data suggests that the 
community setting and the advisers’ social familiarity81 
with the smokers as customers enable such smoker-cen-
tred care, in a way that is potentially greater than is 
possible in GP consultations. This supports other research 
suggesting that community pharmacies are ideally placed 
for smoking cessation and other health behaviour change 
tasks.10–13
Nonetheless, the core set of strategies common across 
both quitter and non-quitter groups focused on the prac-
tical and the medical, biomedical talk and advice (the 
‘voice of medicine’).42 43 This was certainly an important 
part of consultations and appropriate given the pharmacy 
staff member’s role as adviser and the need for such talk 
in the first consultation in particular. But unlike biomed-
ical talk, lifeworld talk was not included in this core set, in 
other words, it was less consistently used. We found, from 
more detailed analysis, that differences between smokers 
in the way lifeworld talk was used could be related to quit 
success or failure.
It appeared that advisers used lifeworld talk to make 
judgements about likely smoker quit success. This then 
compromised its effective use. We found this affected 
non-quitters disproportionately, and this seemed due 
to the adviser focussing on possible problems in those 
they judged as less likely to quit and making assumptions 
about reasons the smoker found it hard to quit. This 
counselling approach was not used in those who went on 
to quit. Our data show that in this way, prejudgements led 
to three sources of misalignment with, or confusion in, 
the smokers who did not quit. First, advisers frequently 
offered casual ‘open-door’ drop-in support between 
consultations to smokers. But these offers were less clear 
or explicit in their purpose when made to non-quitters 
and appear to have simply confused them as to when they 
were meant to attend. Second, praise and willpower talk 
were common in both quitters and non-quitters, but the 
way they were communicated was often poorly matched 
to smoker effort. Extreme statements made in praise of 
non-quitters when they were still smoking created cogni-
tive dissonance. Third, the advisers drew on financial 
and health benefits as motivators for quitting in those 
who then failed to quit and had cited other reasons for 
wanting to quit. The misalignment between the smoker’s 
reasons for smoking or wanting to quit and the adviser’s 
perceptions of what these were would result in the adviser 
setting inappropriate goals for the smoker.72–82
These misalignments may therefore explain why a 
smoker’s sharing of their lifeworld was not always associ-
ated with quit success. This interpretation of the data is 
supported by similar findings in our separate analysis of 
adviser interviews, with some advisers explicitly stating that 
they emphasised particular strategies in those smokers 
they considered would find it harder to quit, to try to help 
them.36 Misalignments push interactants ‘out of sync’ with 
each other, making it hard for them to achieve a common 
goal. Nyugen considers how misalignments in pharmacy 
counselling need to be delicately managed not to affect 
the tenor of the rest of the conversation.62 Misalignments 
were noted by Pilnick49–51 as problematising the advis-
er’s advice giving, but we have shown how they develop 
to create issues in the adviser’s cognitive development of 
what that advice might be as well as how their counselling 
support should be configured.
Our data also show that the advisers drew on some-
times apparently contradictory strategies to induce a 
quit. For example, they often combined reassurance 
of a non-judgemental approach with the use of the 
CO monitor as a surveillance tool. While this seems to 
have been successful, biomedical talk and advice, talk 
of being non-judgemental, monitoring and surveil-
lance and the advisers’ use of authority and expertise 
to prejudge likely smoker success are all premised 
on a power differential between adviser and smoker 
and may therefore appear to sit in dialectical tension 
with the development of shared understandings and 
social familiarity from the community setting. Social 
familiarity and power differentials are not mutu-
ally exclusive but they are less likely to coexist the 
greater the difference in social status between two 
interactants.72 78 81 83 84 Thus, the pharmacy commu-
nity setting provides particular communication 
issues that are less likely to occur in encounters with 
doctors and medical specialists. Social familiarity is 
shown in our data to have the potential to enhance 
quit success and power differentials to compromise 
this, and the best outcomes might be achieved when 
advisers strike a balance between the two, optimising 
the benefits of the community pharmacy setting. 
Figure 2 demonstrates this. Considering recommen-
dations for pharmacy adviser smoking cessation care, 
we found successful quits to be more likely when there 
was more smoker-centred care with counselling plans 
that were based on the smokers’ own lifeworlds and 
that matched strategies such as praise to the smokers’ 
actual rather than predicted behaviours.
strengths and limitations
Our study contributes to current knowledge and prac-
tice with novel data from a pharmacy service that has not 
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Figure 2 Tentative model of misalignment in the community pharmacy NHS Stop Smoking service consultation. NHS, National 
Health Service.
previously been subject to ethnographic study. As this was 
a qualitative study, we considered data from a small and 
varied sample of participating staff members, smokers and 
community pharmacies, adding to richness of the find-
ings. Since we were comparing two groups, we matched 
them on relevant variables to increase the dependability 
of our analysis. We achieved theme saturation within this 
matched pair design, with adequate agreement between 
coders, group data sessions and consideration of negative 
cases in the data adding to credibility and dependability 
of findings. Themes reported in this analysis correspond 
with some of the themes developed separately from 
semistructured qualitative interviews with advisers and 
smokers from the same study.36 Our study has enabled 
us to identify key elements of talk and can be used to 
strengthen consultations and make them more effective.
Our study also has limitations. We were not successful 
in recruiting pharmacy chains and make no claims to 
transferability of the ﬁndings to other pharmacies, partic-
ularly those in more affluent areas. Further, it may not be 
possible to extrapolate findings from these consultations, 
which were undertaken in a private room, to over the 
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counter community pharmacy interactions. In collecting 
naturalistic qualitative data, our aim was rather to provide 
in-depth exploration of communication practices. This 
was usefully achieved. A number of contextual and demo-
graphic variables are known to affect pharmacist–smoker 
communication and quit successes.85 We were unable to 
explore these in our small sample. We did not case match 
by adviser ethnicity or other adviser variables as this would 
have required oversampling for our specific research 
question, which was not intended to explore this, but 
this might be a topic for different research. However, 
we systematically looked for adviser-specific patterns and 
found that our analysis held irrespective of adviser. Partic-
ipants were not blinded to the nature of the research 
and advisers had a potential vested interest in successful 
quits, creating a possible performance eﬀect. However 
the unobtrusive data collection method will have reduced 
this risk with smokers and the effect would have been the 
same for quitters and non-quitters. There may have been 
an intrinsic difference between the quitters and non-quit-
ters before they even entered the consultation room, and 
our study was not designed to explore this. For example, 
although baseline characteristics known to be related to 
quitting, such as gender and age, were taken into account, 
we did not systematically collect data on other poten-
tially significant variables such as number of previous 
quit attempts or medication use. Our thematic analysis 
suggests this would have been useful. The quitters may 
have been successful irrespective of consultation features; 
the availability of support itself may be sufficient.41 85
clinical implications
Advisers had all received NCSCT certification; this 
training focuses on counselling skills but does not 
consider implementation in practice. Nor does it cover 
initial smoker engagement and retention in the service. 
Moreover, while the NCSCT programme has been shown 
to be effective,86 we previously identified through semi-
structured interviews that advisers lacked confidence 
when implementing the training in practice.36 They 
wished for more support that built on and reinforced 
many of the behaviour change techniques learnt through 
the NCSCT scheme and that also addressed client-cen-
tred consultation skills.36 These issues may partly explain 
the advisers’ inconsistencies in the delivery of and 
content of the consultations. To improve their practice, 
advisers might reflect on their use of the considerable 
lifeworld talk generated by smokers through their social 
familiarity with the pharmacy advisers. Lifeworld talk 
should be used to modify adviser counselling to suit key 
external psychosocial factors, namely the context within 
which the quit attempt is made and the related motiva-
tors to quitting. Our data suggest that currently advisers 
may instead modify the consultation to suit their assump-
tions about internal psychological factors such as the 
smoker’s capacity to quit or motivation for quitting.41 In 
this way, advisers sometimes develop the consultation in 
ways that, while well meaningly intended, run the risk 
of being counter-productive. For smokers judged by 
them as less likely to quit, this may include inappropri-
ately overemphasising some support strategies (such as 
praise, managing expectations) and underplaying others 
(such as the need for willpower and the importance of 
adviser support). Our data illustrate the potential for 
misalignment that this creates. Moreover, the exagger-
ated praise we saw in non-quitter reductions in smoking 
conflicts with the ‘not a puff’ rule recommended by the 
NCSCT. Advisers should use findings from our study to 
clarify where they might usefully capitalise on the social 
closeness they seem to share with the smokers they see, 
with more appropriate use of lifeworld talk and more 
use of smoker-declared motivators during motivational 
interviewing.
recommendations for research
Our study only considers short-term outcomes, something 
we are addressing with further research. The analyses 
have been used to inform the development and content 
of our training intervention for pharmacy Stop Smoking 
advisers, evaluated in a cluster randomised trial (grant 
number RP-PG-0609–10181). This intervention comple-
ments NCSCT training and is not intended to replace it. 
We are currently exploring the microdetail of the talk 
in the consultations using conversation analysis with a 
view to further dissemination and use. Our study could 
be replicated in less disadvantaged areas or in specific 
minority groups.
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